Literature DB >> 29460273

Pharmacogenetic Information in Clinical Guidelines: The European Perspective.

Jesse J Swen1,2, Marga Nijenhuis3, Mandy van Rhenen3, Nienke J de Boer-Veger4, Anne-Marie Buunk5, Elisa J F Houwink6, Hans Mulder7, Gerard A Rongen8,9, Ron H N van Schaik10, Jan van der Weide11, Bob Wilffert12, Vera H M Deneer13, Henk-Jan Guchelaar1,2.   

Abstract

Surveys among pharmacists and physicians show that these healthcare professionals have successfully adopted the concept of pharmacogenomics (PGx).1-3 In addition, patients are willing to consent to participate in PGx implementation studies.4 However, the surveys also show that healthcare professionals do not frequently order or recommend a PGx test.1,2 Among others, a frequently perceived hurdle for clinical uptake of PGx is the availability of guidelines translating PGx test results into clinical actions for individual patients.5,6.
© 2018 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh：

Year:  2018        PMID： 29460273     DOI： 10.1002/cpt.1049

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  23 in total

1.  Implementation and obstacles of pharmacogenetics in clinical practice: An international survey.

Authors:  Elizabeth Abou Diwan; Ralph I Zeitoun; Lea Abou Haidar; Ingolf Cascorbi; Nathalie Khoueiry Zgheib
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

2.  Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity.

Authors:  Vasileios Fragoulakis; Rossana Roncato; Chiara Dalle Fratte; Fabrizio Ecca; Marina Bartsakoulia; Federico Innocenti; Giuseppe Toffoli; Erika Cecchin; George P Patrinos; Christina Mitropoulou
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

3.  Re: Pharmacogenetic Testing Options Relevant to Psychiatry in Canada.

Authors:  Martin Dawes; Hagit Katzov-Eckert; Andrea Paterson; Diana Dawes
Journal:  Can J Psychiatry       Date:  2020-05-13       Impact factor: 4.356

4.  Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.

Authors:  Jurriaan M J L Brouwer; Marga Nijenhuis; Bianca Soree; Henk-Jan Guchelaar; Jesse J Swen; Ron H N van Schaik; Jan van der Weide; Gerard A P J M Rongen; Anne-Marie Buunk; Nienke J de Boer-Veger; Elisa J F Houwink; Roos van Westrhenen; Bob Wilffert; Vera H M Deneer; Hans Mulder
Journal:  Eur J Hum Genet       Date:  2021-11-16       Impact factor: 5.351

5.  The Integrating Pharmacogenetics in Clinical Care (I-PICC) Study: Protocol for a point-of-care randomized controlled trial of statin pharmacogenetics in primary care.

Authors:  Jason L Vassy; Charles A Brunette; Nilla Majahalme; Sanjay Advani; Lauren MacMullen; Cynthia Hau; Andrew J Zimolzak; Stephen J Miller
Journal:  Contemp Clin Trials       Date:  2018-10-24       Impact factor: 2.226

Review 6.  Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprine.

Authors:  Laura L Daniel; Alyson L Dickson; Cecilia P Chung
Journal:  Clin Rheumatol       Date:  2020-07-02       Impact factor: 2.980

Review 7.  Pharmacogenomic Clinical Decision Support: A Review, How-to Guide, and Future Vision.

Authors:  Dyson T Wake; D Max Smith; Sadaf Kazi; Henry M Dunnenberger
Journal:  Clin Pharmacol Ther       Date:  2021-08-29       Impact factor: 6.903

8.  Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.

Authors:  Liewei Wang; Steven E Scherer; Suzette J Bielinski; Donna M Muzny; Leila A Jones; John Logan Black; Ann M Moyer; Jyothsna Giri; Richard R Sharp; Eric T Matey; Jessica A Wright; Lance J Oyen; Wayne T Nicholson; Mathieu Wiepert; Terri Sullard; Timothy B Curry; Carolyn R Rohrer Vitek; Tammy M McAllister; Jennifer L St Sauver; Pedro J Caraballo; Konstantinos N Lazaridis; Eric Venner; Xiang Qin; Jianhong Hu; Christie L Kovar; Viktoriya Korchina; Kimberly Walker; HarshaVardhan Doddapaneni; Tsung-Jung Wu; Ritika Raj; Shawn Denson; Wen Liu; Gauthami Chandanavelli; Lan Zhang; Qiaoyan Wang; Divya Kalra; Mary Beth Karow; Kimberley J Harris; Hugues Sicotte; Sandra E Peterson; Amy E Barthel; Brenda E Moore; Jennifer M Skierka; Michelle L Kluge; Katrina E Kotzer; Karen Kloke; Jessica M Vander Pol; Heather Marker; Joseph A Sutton; Adrijana Kekic; Ashley Ebenhoh; Dennis M Bierle; Michael J Schuh; Christopher Grilli; Sara Erickson; Audrey Umbreit; Leah Ward; Sheena Crosby; Eric A Nelson; Sharon Levey; Michelle Elliott; Steve G Peters; Naveen Pereira; Mark Frye; Fadi Shamoun; Matthew P Goetz; Iftikhar J Kullo; Robert Wermers; Jan A Anderson; Christine M Formea; Razan M El Melik; John D Zeuli; Joseph R Herges; Carrie A Krieger; Robert W Hoel; Jodi L Taraba; Scott R St Thomas; Imad Absah; Matthew E Bernard; Stephanie R Fink; Andrea Gossard; Pamela L Grubbs; Therese M Jacobson; Paul Takahashi; Sharon C Zehe; Susan Buckles; Michelle Bumgardner; Colette Gallagher; Kelliann Fee-Schroeder; Nichole R Nicholas; Melody L Powers; Ahmed K Ragab; Darcy M Richardson; Anthony Stai; Jaymi Wilson; Joel E Pacyna; Janet E Olson; Erica J Sutton; Annika T Beck; Caroline Horrow; Krishna R Kalari; Nicholas B Larson; Hongfang Liu; Liwei Wang; Guilherme S Lopes; Bijan J Borah; Robert R Freimuth; Ye Zhu; Debra J Jacobson; Matthew A Hathcock; Sebastian M Armasu; Michaela E McGree; Ruoxiang Jiang; Tyler H Koep; Jason L Ross; Matthew G Hilden; Kathleen Bosse; Bronwyn Ramey; Isabelle Searcy; Eric Boerwinkle; Richard A Gibbs; Richard M Weinshilboum
Journal:  Genet Med       Date:  2022-03-21       Impact factor: 8.864

Review 9.  Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review.

Authors:  Nada Božina; Lana Ganoci; Livija Simičević; Katarina Gvozdanović; Iva Klarica Domjanović; Margareta Fistrek Prlić; Tena Križ; Ana Borić Bilušić; Mario Laganović; Tamara Božina
Journal:  Arh Hig Rada Toksikol       Date:  2021-06-28       Impact factor: 2.078

10.  Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).

Authors:  Maja Matic; Marga Nijenhuis; Bianca Soree; Nienke J de Boer-Veger; Anne-Marie Buunk; Elisa J F Houwink; Hans Mulder; Gerard A P J M Rongen; Jan van der Weide; Bob Wilffert; Jesse J Swen; Henk-Jan Guchelaar; Vera H M Deneer; Ron H N van Schaik
Journal:  Eur J Hum Genet       Date:  2021-07-15       Impact factor: 5.351
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.